Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2019-09-02 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
关于5%以上股东减持股份进展情况的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the progress of shareholding reduction by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the time period, methods, prices, and compliance with relevant regulations. The document does not contain financial statements or performance data but focuses on shareholding changes by a major shareholder. This fits the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels crossing thresholds.
2019-09-02 Chinese
关于实际控制人部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by a major shareholder (actual controller) of the company. It details the number of shares released from pledge, dates, and related information about share pledges. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about share pledge status, which does not fit into more specific categories like Major Shareholding Notification (MRQ) because it concerns pledge release rather than ownership threshold changes.
2019-09-02 Chinese
2019年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 年半年度报告全文" which translates to "2019 Semi-Annual Report Full Text." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, notes on accounting policies, audit report section (not audited), and other comprehensive financial data for the half-year period ending June 30, 2019. The length is substantial (15,000 characters) and includes actual financial data and analysis, not just an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2019
2019-08-28 Chinese
2019年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '2019 半年度报告摘要' which translates to '2019 Semi-Annual Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, cash flow, earnings per share, and asset information. It also discusses changes in accounting policies, scope of consolidation, and business segment performance. The length of the document (8833 characters) and the presence of substantive financial data and analysis confirm it is a financial report rather than a brief announcement or certification. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with comprehensive financial information and management discussion. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2019
2019-08-28 Chinese
2019年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the management and usage of funds raised through non-public stock issuances by 瑞康医药集团股份有限公司 (Ruikang Pharmaceutical Group Co., Ltd.) for the half-year period ending June 30, 2019. It includes specifics on the amounts raised, the timing of fund receipt, the allocation and usage of these funds, changes in investment projects, and compliance with regulatory requirements. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and includes audit confirmations from an accounting firm. The content is focused on the special report regarding the deposit and use of raised funds, which is a typical disclosure for companies that have conducted capital raising activities. This type of document is best classified as a Capital/Financing Update (CAP), as it provides updates on fundraising activities and the use of capital raised, rather than being a full annual or interim financial report, audit report, or other types of filings.
2019-08-28 Chinese
第三届监事会第十九次会议决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of resolutions passed at the 19th meeting of the third Supervisory Board of Ruikang Pharmaceutical Group Co., Ltd. It includes approval of the company's 2019 semi-annual report and a special report on the use of raised funds. The document states voting results and confirms compliance with relevant laws. The text is short (814 characters) and primarily reports on meeting decisions and voting outcomes rather than containing the full semi-annual report or detailed financial data. Therefore, it is not the interim report itself but an announcement related to governance and voting results. Given the focus on voting results and official resolutions, the best fitting category is Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-08-28 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.